Central mucoepidermoid carcinoma: An up-to-date analysis of 147 cases and review of prognostic factors

J Craniomaxillofac Surg. 2018 Jan;46(1):162-167. doi: 10.1016/j.jcms.2017.10.020. Epub 2017 Oct 31.

Abstract

Objective: To integrate the available data published on central mucoepidermoid carcinoma (CMC) into a comprehensive analysis of its clinical aspects, histology, treatment, and prognostic factors.

Methods: An electronic search was undertaken in July 2017. Eligibility criteria for publications included having clinical, histological, treatment, and time of follow-up data to confirm the diagnosis.

Results: In addition, gender, histological grade, conservative treatment, and lymph node metastasis were significant independent prognostic factors.

Conclusion: Male patients with histological grade III CMC of the jaw bone, who used conservative treatment as the main treatment, and presented with lymph node metastasis, were more likely to have a worse prognosis.

Keywords: Bone lesion; Central mucoepidermoid carcinoma; Jaw bones; Prognostic.

Publication types

  • Review

MeSH terms

  • Adult
  • Carcinoma, Mucoepidermoid* / diagnosis
  • Carcinoma, Mucoepidermoid* / therapy
  • Female
  • Humans
  • Jaw Neoplasms* / diagnosis
  • Jaw Neoplasms* / therapy
  • Male
  • Prognosis